RABISIN, ενέσιμο εναιώρημα
RABISIN, ενέσιμο εναιώρημα
Pooblaščeno
- Rabies virus, strain G52, Inactivated
Identifikacija zdravila
Ime zdravila:
RABISIN, ενέσιμο εναιώρημα
Učinkovina:
- Na voljo samo v English
Ciljne živalske vrste:
-
govedo
Pot uporabe:
-
intramuskularna uporaba
-
Subkutana uporaba
Podatki o zdravilu
Učinkovina / Jakost:
-
Na voljo samo v English2.09log 10 optical density 501.00dose
Farmacevtska oblika:
-
Suspenzija za injiciranje
Withdrawal period by route of administration:
-
intramuskularna uporaba
- Horse
-
Not applicableno withdrawal period
-
- govedo
-
Not applicableno withdrawal period
-
- Sheep
-
Not applicableno withdrawal period
-
- Dog
-
Not applicableno withdrawal period
-
- Cat
-
Not applicableno withdrawal period
-
- Ferret
-
Not applicableno withdrawal period
-
-
Subkutana uporaba
- govedo
-
Not applicableno withdrawal period
-
- Sheep
-
Not applicableno withdrawal period
-
- Dog
-
Not applicableno withdrawal period
-
- Cat
-
Not applicableno withdrawal period
-
- Ferret
-
Not applicableno withdrawal period
-
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
- QI07AA02
Pravni status za dobavo / izdajo zdravila:
-
Zdravilo, ki se izdaja na veterinarski recept
Status dovoljenja:
-
Valid
Available in:
-
Greece
Dodatne informacije
Pravna podlaga za izdajo dovoljenja za promet z zdravilom:
- Na voljo samo v English
Imetnik dovoljenja za promet z zdravilom:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
- Boehringer Ingelheim Animal Health France
Pristojni organ:
- National Organization For Medicines
Številka dovoljenja :
- 57429/02-06-2020/K-0013001
Datum spremembe statusa dovoljenja:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Kako koristna je bila ta stran?: